September 29, 2010 — A new oral formulation of tranexamic acid may be safe and effective for treatment of heavy menstrual bleeding, according to the results of a phase 3 trial by Andrea S. Lukes, MD, ...
Tranexamic acid is highly efficacious for the treatment of melasma, with optimal outcomes seen through oral administration plus routine topical agents. The efficacy of tranexamic acid alone against ...
Please provide your email address to receive an email when new articles are posted on . Oral tranexamic acid may improve symptoms of refractory melasma in Asian patients without risk factors or a ...
HY-004 provides a new treatment alternative for use in patients on anti-coagulant therapies undergoing dental procedures that have a risk of bleeding or complication HY-004 administered locally had ...
Please provide your email address to receive an email when new articles are posted on . DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed all dosing ...
Tinted sunscreens can help protect against the sun’s UV rays and should be worn if you are getting treated for melasma. Andy Newman AP Tranexamic acid has been used as a topical ingredient to help ...
The Vichy LiftActiv B3 Serum is another Dr. Gohara recommendation as it combines tranexamic acid with niacinamide and gentle ...
Nonsteroidal anti-inflammatory drugs (NSAIDs) may help control or prevent excessive menstrual bleeding associated with copper-containing intrauterine devices (Cu-IUDs), according to a new ...
In this condition, the dark skin areas show brown or gray‑brown colors, which appear on the cheeks, forehead, nose bridge, ...
Interim results of a study conducted by researchers at Hospital for Special Surgery (HSS) suggest that oral tranexamic acid (TXA) is non-inferior to intravenous (IV) TXA in preventing blood loss in ...
Hyloris Pharmaceuticals SA, a specialty biopharma company, announced positive results from a phase 1 study of HY-004, an antifibrinolytic agent, tranexamic acid, as an oral mouth rinse proprietary ...